EPHA2 and glioma: In addition, treatment with these EphA2-specific T cells suppressed EphA2-positive U373 glioma xenografts in severe combined immunodeficiency (SCID) mice and markedly increased animal survival in comparison with non-treated mice and those administered non-transduced T cells [79].